Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders

Details for Australian Patent Application No. 2009310926 (hide)

Owner M's Science Corporation

Inventors Mita, Shiro; Kobayashi, Naoyuki

Agent Freehills

Pub. Number AU-A-2009310926

PCT Pub. Number WO2010/050435

Priority 2008-276045 27.10.08 JP

Filing date 26 October 2009

Wipo publication date 6 May 2010

International Classifications

C07C 211/40 (2006.01) Compounds containing amino groups bound to a carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/145 (2006.01) - having sulfur atoms, e.g. thiurams (NC(S)SC(S)N or NC(S)SSC(S)N)

A61K 31/47 (2006.01) - Quinolines

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 217/16 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 217/20 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 217/62 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 323/25 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 215/06 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/050435 Priority application(s): WO2010/050435

1 September 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 May and 12 Aug 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009310927-Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders

2009310912-Peptide having anti-diabetic activity and use thereof